It's important to note that

Thus, one important question one can ask here is how welldFnn(ˆµn,ˆνm)approximatesdFnn(µ,ν).

Neural Information Processing Systems http://nips.cc/

We study the limits and capability of public-data assisted differentially private (P A-DP) algorithms. Specifically, we focus on the problem of stochastic convex optimization (SCO) with either labeled or unlabeled public data.

As major progress in LLM-based long-form text generation enables paradigms such as retrieval-augmented generation (RAG) and inference-time scaling, safely incorporating private information into the generation remains a critical open question. We present InvisibleInk, a highly scalable long-form text generation framework satisfying rigorous differential privacy guarantees with respect to the sensitive reference texts. It interprets sampling from the LLM's next-token-distribution as the exponential mechanism over the LLM logits with two innovations. First, we reduce the privacy cost by isolating and clipping only the sensitive information in the model logits (relative to the public logits). Second, we improve text quality by sampling without any privacy cost from a small superset of the top-$k$ private tokens. Empirical evaluations demonstrate a consistent $8\times$ (or more) reduction in computation cost over state-of-the-art baselines to generate long-form private text of the same utility across privacy levels. InvisibleInk is able to generate, for the first time, high-quality private long-form text at less than $4$-$8\times$ times the computation cost of non-private generation, paving the way for its practical use. We open-source a pip-installable Python package (invink) for InvisibleInk at https://github.com/cerai-iitm/invisibleink.

Diabetic Retinopathy (DR) remains a leading cause of preventable blindness, with early detection critical for reducing vision loss worldwide. Over the past decade, deep learning has transformed DR screening, progressing from early convolutional neural networks trained on private datasets to advanced pipelines addressing class imbalance, label scarcity, domain shift, and interpretability. This survey provides the first systematic synthesis of DR research spanning 2016-2025, consolidating results from 50+ studies and over 20 datasets. We critically examine methodological advances, including self- and semi-supervised learning, domain generalization, federated training, and hybrid neuro-symbolic models, alongside evaluation protocols, reporting standards, and reproducibility challenges. Benchmark tables contextualize performance across datasets, while discussion highlights open gaps in multi-center validation and clinical trust. By linking technical progress with translational barriers, this work outlines a practical agenda for reproducible, privacy-preserving, and clinically deployable DR AI. Beyond DR, many of the surveyed innovations extend broadly to medical imaging at scale.